Results 131 to 140 of about 92,418 (213)

Corticosteroid-resistant Terbinafine-induced Acute Generalized Exanthematous Pustulosis: Therapeutic Challenges and Clinical Infection Overlap. [PDF]

Acta Derm Venereol
Svizzero A, Vassallo C, Michelerio A, Selimi A, Nisi M, Fiandrino G, Brazzelli V.   +6 more
europepmc   +1 more source

Effectiveness of Abrocitinib in Cyclosporine-Resistant Atopic Dermatitis: A Real-world Experience from the Indian Subcontinent.

Indian J Dermatol
De A, Chakraborty D, Ahmed SKS, Gupta S, Dhar S, Chatterjee M.   +5 more
europepmc   +1 more source

Real-world effectiveness and safety of tralokinumab in moderate-to-severe atopic dermatitis with malignancy, chronic infections, and multimorbidity. [PDF]

Dermatol Ther (Heidelb)
Melgosa Ramos FJ, Mercader P, Santos Alarcón S, Dominguez Liron N, Bernabeu A, Rodriguez Serna M, Fernandez-Crehuet P, Silvestre JF.   +7 more
europepmc   +1 more source

Severe Adult HLH/MAS With SPTCL-Like Panniculitis: A Phenotype-Guided, Resource-Adapted Therapeutic Strategy Without Cytotoxic Therapy. [PDF]

Clin Case Rep
Taha HM, Marouf O, Taha KH.
europepmc   +1 more source

Some of the Newest Therapeutic Methods in Canine Atopic Dermatitis. [PDF]

Vet Sci
Mazilu CC, Strichea AH, Solcan G.
europepmc   +1 more source

Cyclosporine related adverse events in aplastic anemia patients treated with immunosuppressive therapy. [PDF]

Ann Hematol
Xing L, Yang W, Fan H, Li J, Zhao Y, Liang W, Shi J, Zhang F, Zhao X.   +8 more
europepmc   +1 more source

Kawasaki Disease in a Child With Trisomy 18 Treated With Initial Combination Therapy, Including Cyclosporine. [PDF]

Case Rep Pediatr
Sahara Y, Yagi N, Watanabe Y, Aoki K, Iwaku T, Tominaga M, Ikeda H.   +6 more
europepmc   +1 more source

Pure Red Cell Aplasia as an Isolated Paraneoplastic Manifestation of Thymoma: A Case Report and Literature Review. [PDF]

Clin Case Rep
Amer H, Alajlani M, Jamle MR, Almanfe H, Shbat M, Saif MAA, Abdulrazzak A, Nabhan A, Darwish B.   +8 more
europepmc   +1 more source

Efficacy of combined JAK1/2 inhibition and cyclosporine in paediatric-onset Still's disease with lung involvement: a case report. [PDF]

Pediatr Rheumatol Online J
Palmeri S, Lancieri M, Ferro J, Salvati P, Cheli M, Papa R, Rosina S, Volpi S, Vellone VG, Ravelli A, Gattorno M, Caorsi R.   +11 more
europepmc   +1 more source

Effectiveness and safety of cyclosporine A in moderate to severe COVID-19: a randomized, open-label trial. [PDF]

Sci Rep
Zidan AA, Gad AYS, Zakaria NH, El-Hariri HM, Elsharnouby NM, Helmy MW, El-Setouhy M.   +6 more
europepmc   +1 more source